Poolbeg Pharma (POLB)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 6.65p
   
  • Change Today:
      0.000p
  • 52 Week High: 9.19
  • 52 Week Low: 3.55
  • Currency: UK Pounds
  • Shares Issued: 763.44m
  • Volume: 460,488
  • Market Cap: £50.77m
  • Beta: 0.00

Poolbeg Pharma Overview

Poolbeg Pharma is a clinical stage infectious disease pharmaceutical company, with a capital light clinical model which the Directors believe enables it to develop multiple products faster and more cost effectively than the traditional biotech model. Poolbeg has aspirations to become the “one-stop shop” for Big Pharma seeking mid-stage products to license or acquire.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn n/a n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue n/a n/a
Pr/Book 5.5  
Latest F'cast
Revenue n/a n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

Poolbeg Pharma Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-21 n/a (2.34) (0.74)p n/a n/a n/a n/a 0.0%
31-Dec-22 n/a (4.78) (0.94)p n/a n/a n/a n/a 0.0%
31-Dec-23 n/a (3.93) (0.79)p n/a n/a n/a n/a 0.0%
31-Dec-24 n/a (5.94) (1.16)p n/a n/a n/a n/a 0.0%
31-Dec-25 n/a (5.77) (0.94)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Poolbeg Pharma Company Announcements

No recent information was found.

Poolbeg Pharma ShareCast News

Director dealings: Poolbeg Pharma co-founder rai... 25-Jun-2025 ShareCast
Poolbeg Pharma extends cash runway after raising... 23-May-2025 ShareCast
Poolbeg raises nearly £5m to progress clinical t... 20-May-2025 ShareCast

Latest Poolbeg Pharma Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

Poolbeg Pharma Market Data

Currency UK Pounds
Share Price 6.65p
Change Today 0.000p
% Change 0.00 %
52 Week High 9.19
52 Week Low 3.55
Volume 460,488
Shares Issued 763.44m
Market Cap £50.77m
Beta 0.00

Poolbeg Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
61.42% below the market average61.42% below the market average61.42% below the market average61.42% below the market average61.42% below the market average
17.07% below the sector average17.07% below the sector average17.07% below the sector average17.07% below the sector average17.07% below the sector average
Price Trend
17.17% above the market average17.17% above the market average17.17% above the market average17.17% above the market average17.17% above the market average
20.93% above the sector average20.93% above the sector average20.93% above the sector average20.93% above the sector average20.93% above the sector average
Income Not Available
Growth Not Available

Poolbeg Pharma Dividends

No dividends found

Trades for 28-Oct-2026

Time Volume / Share Price
16:12 3,419 @ 6.51p
15:41 319 @ 6.50p
15:25 23,315 @ 6.65p
15:06 18,505 @ 6.52p
11:12 132 @ 6.80p

Poolbeg Pharma Key Personnel

CEO Jeremy Skillington
CFO Ian O’Connel

Top of Page